Tumor risks of finerenone in patients with type 2 diabetes mellitus complicated with chronic kidney disease: a meta-analysis and systematic review of randomized controlled trials

• Үндсэн зохиолчид: Yue Du (Зохиогч), Gui Cao (Зохиогч), Linlin Gu (Зохиогч), Yuehong Chen (Зохиогч), Jingyu Liu (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Frontiers Media S.A., 2024-01-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Introduction: This study aimed to assess the tumor risk of finerenone in individuals with type 2 diabetes mellitus (T2DM) aggravated by chronic kidney disease (CKD).Methods: A thorough search in the OVID Medline, OVID EMBASE, and Cochrane Library databases from their creation through 2 November 2022...